several histamine h2 receptor antagonists and the h+ , k ( + ) -atpase inhibitor , omeprazole , have been shown to be capable of controlling gastric acid secretion safely and effectively in patients with zollinger-ellison syndrome .
C0028978
omeprazole
C0043515
zollinger-ellison syndrome